Skip to main content
Top
Published in: Breast Cancer Research 1/1999

01-12-1999 | Paper Report

Connexin gap junctions in breast cancer

Author: Robert Clarke

Published in: Breast Cancer Research | Issue 1/1999

Login to get access

Excerpt

Gap junctions are intercellular channels that are formed by members of a family of proteins termed the connexins (Cxs). Gap junctions play an important role in cellular functions, including the regulation of cell growth and differentiation. …
Literature
1.
go back to reference Laird DW, Fistouris P, Batist G, Alpert L, Huynh HT, Carystinos GD, Alaoui-Jamali MA: Deficiency of connexin43 gap junctions is an independent marker for breast tumors. Cancer Res . 1999, 59: 4104-4110.PubMed Laird DW, Fistouris P, Batist G, Alpert L, Huynh HT, Carystinos GD, Alaoui-Jamali MA: Deficiency of connexin43 gap junctions is an independent marker for breast tumors. Cancer Res . 1999, 59: 4104-4110.PubMed
Metadata
Title
Connexin gap junctions in breast cancer
Author
Robert Clarke
Publication date
01-12-1999
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 1/1999
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr-1999-66614

Other articles of this Issue 1/1999

Breast Cancer Research 1/1999 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine